SBI Long Term Equity Fund Buys 58,30,330 Shares in Smallcap Pharmacy Company: Stock Reports 166 Per Cent PAT Surge
The company reported a significant surge in its quarterly earnings, with consolidated net profit rising 165.97 per cent to Rs 38.74 crore in Q2 FY25, compared to Rs 14.57 crore in Q2 FY24.
SBI Long-Term Equity Fund has acquired a stake of 4.88 per cent in Medplus Health Services, buying 58,30,330 shares in the pharmacy retailer during the July to September 2024 quarter. MedPlus is the second-largest pharmacy retail chain in India, operating 4,552 stores across 12 states and one union territory, with its outlets spread across metro, tier-one, and tier-two cities. The company provides a range of pharmaceutical, wellness, and FMCG products.
Q2 FY25 Highlights
MedPlus Health Services reported a significant surge in its quarterly earnings, with consolidated net profit rising 165.97 per cent to Rs 38.74 crore in Q2 FY25, compared to Rs 14.57 crore in Q2 FY24. Revenue from operations also increased, showing an 11.9 per cent rise to Rs 1,576.17 crore over the same period.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
The company’s operating earnings before interest, taxes, depreciation, and amortization (EBITDA) for the September 2024 quarter grew by 80.24 per cent, reaching Rs 73.9 crore, up from Rs 41 crore in Q2 FY24. Additionally, MedPlus saw an improvement in its EBITDA margin, which expanded by 180 basis points to 4.7 per cent in Q2 FY25, compared to 2.9 per cent in the corresponding quarter of the previous fiscal year.
MedPlus also reported a gross margin increase, reaching 23.7 per cent in Q2 FY25 compared to 21.6 per cent in Q2 FY24. The company expanded its footprint, adding 108 stores during the quarter, which brought its total store count to 4,552 as of September 2024.
Disclaimer: This article is for informational purposes only and not investment advice.